Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Geisslinger

Showing results (61-70 of 441) with videos related to

Pageof 45
Sort By:
Pain|March 1, 2011
MicroRNAs as new players in the pain gameEllen Niederberger, Katharina Kynast, Jörn Lötsch, et al.
Anesthesiology|September 18, 2025
Topical Analgesics: Pharmacology and Clinical ApplicationsMarco Sisignano, Andrew S C Rice, Gerd Geisslinger
Nature Reviews. Neurology|May 27, 2017
Drugging the pain epigenomeEllen Niederberger, Eduard Resch, Michael J Parnham, et al.
Biochemical Pharmacology|May 9, 2002
Verapamil decreases glucuronidase activity in the gutJörn Lötsch, Bernhard Sperker, Heyo K Kroemer, et al.
Trends in Molecular Medicine|November 28, 2018
Ceramides as Novel Disease BiomarkersJennifer Kurz, Michael J Parnham, Gerd Geisslinger, et al.
Journal of the National Cancer Institute|June 8, 2006
Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitorsSabine Grösch, Thorsten Jürgen Maier, Susanne Schiffmann, et al.
Pharmacology & Therapeutics|February 14, 2019
Potential biomarkers for persistent and neuropathic pain therapyMarco Sisignano, Jörn Lötsch, Michael J Parnham, et al.
Pharmacology & Therapeutics|November 14, 2012
NOXious signaling in pain processingWiebke Kallenborn-Gerhardt, Katrin Schröder, Gerd Geisslinger, et al.
EMBO Molecular Medicine|September 19, 2019
4 Ds in health research-working together toward rapid precision medicineEllen Niederberger, Michael J Parnham, Jochen Maas, et al.
Plos One|December 24, 2011
Additive antinociceptive effects of a combination of vitamin C and vitamin E after peripheral nerve injuryRuirui Lu, Wiebke Kallenborn-Gerhardt, Gerd Geisslinger, et al.
Pageof 45

Showing results (61-70 of 441) with videos related to

Sort By:
Pageof 45
Pain|March 1, 2011
MicroRNAs as new players in the pain gameEllen Niederberger, Katharina Kynast, Jörn Lötsch, et al.
Anesthesiology|September 18, 2025
Topical Analgesics: Pharmacology and Clinical ApplicationsMarco Sisignano, Andrew S C Rice, Gerd Geisslinger
Nature Reviews. Neurology|May 27, 2017
Drugging the pain epigenomeEllen Niederberger, Eduard Resch, Michael J Parnham, et al.
Biochemical Pharmacology|May 9, 2002
Verapamil decreases glucuronidase activity in the gutJörn Lötsch, Bernhard Sperker, Heyo K Kroemer, et al.
Trends in Molecular Medicine|November 28, 2018
Ceramides as Novel Disease BiomarkersJennifer Kurz, Michael J Parnham, Gerd Geisslinger, et al.
Journal of the National Cancer Institute|June 8, 2006
Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitorsSabine Grösch, Thorsten Jürgen Maier, Susanne Schiffmann, et al.
Pharmacology & Therapeutics|February 14, 2019
Potential biomarkers for persistent and neuropathic pain therapyMarco Sisignano, Jörn Lötsch, Michael J Parnham, et al.
Pharmacology & Therapeutics|November 14, 2012
NOXious signaling in pain processingWiebke Kallenborn-Gerhardt, Katrin Schröder, Gerd Geisslinger, et al.
EMBO Molecular Medicine|September 19, 2019
4 Ds in health research-working together toward rapid precision medicineEllen Niederberger, Michael J Parnham, Jochen Maas, et al.
Plos One|December 24, 2011
Additive antinociceptive effects of a combination of vitamin C and vitamin E after peripheral nerve injuryRuirui Lu, Wiebke Kallenborn-Gerhardt, Gerd Geisslinger, et al.
Pageof 45